We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTWO icon
501
Take-Two Interactive
TTWO
$46.3B
$1.82M 0.01%
11,809
+132
+1% +$20K
HAL icon
502
Halliburton
HAL
$26B
$1.8M 0.01%
62,054
-498,679
-89% -$15.7M
COR icon
503
Cencora
COR
$62.2B
$1.77M 0.01%
7,864
-33
-0.4% -$7.66K
CTVA icon
504
Corteva
CTVA
$60.1B
$1.72M 0.01%
29,296
+263
+0.9% +$14.4K
DVN icon
505
Devon Energy
DVN
$51.1B
$1.72M 0.01%
43,994
+172
+0.4% +$7.57K
HIW icon
506
Highwoods Properties
HIW
$3.88B
$1.71M 0.01%
+50,926
New +$1.56M
WDC icon
507
Western Digital
WDC
$165B
$1.69M 0.01%
32,720
-10,840
-25% -$548K
ARKK icon
508
ARK Innovation ETF
ARKK
$5.66B
$1.69M 0.01%
35,520
ANSS
509
DELISTED
Ansys
ANSS
$1.66M 0.01%
5,199
+105
+2% +$33.4K
TEAM icon
510
Atlassian
TEAM
$26.5B
$1.65M 0.01%
10,421
+573
+6% +$94.2K
BNS icon
511
Scotiabank
BNS
$106B
$1.65M 0.01%
30,285
+8,333
+38% +$404K
SHOP icon
512
Shopify
SHOP
$169B
$1.65M 0.01%
20,541
-118,951
-85% -$8.22M
SWK icon
513
Stanley Black & Decker
SWK
$14.5B
$1.64M 0.01%
14,858
-219,296
-94% -$21M
SKX
514
DELISTED
Skechers
SKX
$1.63M 0.01%
24,376
-19,991
-45% -$1.31M
BXP icon
515
Boston Properties
BXP
$11.8B
$1.61M 0.01%
20,048
+3,167
+19% +$227K
BAH icon
516
Booz Allen Hamilton
BAH
$8.54B
$1.61M 0.01%
9,864
-715
-7% -$109K
TYL icon
517
Tyler Technologies
TYL
$14.1B
$1.6M 0.01%
2,747
+416
+18% +$234K
TW icon
518
Tradeweb Markets
TW
$23B
$1.57M 0.01%
12,715
+12
+0.1% +$1.36K
PKG icon
519
Packaging Corp of America
PKG
$22.2B
$1.57M 0.01%
7,292
SKT icon
520
Tanger
SKT
$4.81B
$1.56M 0.01%
+46,929
New +$1.37M
TRU icon
521
TransUnion
TRU
$15.9B
$1.54M 0.01%
14,731
+1,770
+14% +$160K
VRSN icon
522
VeriSign
VRSN
$26.4B
$1.52M 0.01%
8,028
-935
-10% -$169K
TDY icon
523
Teledyne Technologies
TDY
$29.4B
$1.5M 0.01%
3,431
-406
-11% -$168K
DKS icon
524
Dick's Sporting Goods
DKS
$18.6B
$1.49M 0.01%
7,123
+4,933
+225% +$1.05M
LPLA icon
525
LPL Financial
LPLA
$27.4B
$1.47M 0.01%
6,339
-1,771
-22% -$399K

Similar funds

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.